Twist Bioscience Corp

Stock Chart, Company Information, and Scan Results

$31.18(as of Dec 3, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Twist Bioscience Corp Company Information, Fundamentals, and Technical Indicators

Stock Price$31.18
Ticker SymbolTWST
ExchangeNasdaq
SectorHealthcare
IndustryDiagnostics & Research
Employees979
CountyUSA
Market Cap$1,816.1M
EBIDTA-114.3M
10-Day Moving Average29.50
P/E Ratio-24.30
20-Day Moving Average29.54
Forward P/E Ratio0.00
50-Day Moving Average30.34
Earnings per Share-1.30
200-Day Moving Average33.25
Profit Margin-27.25%
RSI54.21
Shares Outstanding61.1M
ATR2.11
52-Week High55.33
Volume1,364,154
52-Week Low23.30
Most Recent Support Level28.90
Book Value473.0M
Most Recent Resistance Level32.10
P/B Ratio3.98
Upper Keltner34.28
P/S Ratio5.00
Lower Keltner24.79
Debt-to-Equity Ratio34.28
Next Earnings DateUnknown
Cash Surplus91.6M
Next Ex-Dividend DateUnknown

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corp In Our Stock Scanner

As of Dec 04, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Morning StarScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.